drugset / Trial / NCT03301558
The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients
Phase 2
Withdrawn
Prim. Priv. Doz. Dr. Daniel Cejka
Medice Arzneimittel Pütter GmbH & Co KG · collab
RandomizedCrossoverOpen-labelDiagnostic
Summary
This is a single-center, prospective, open-label, randomized, cross-over study.
Timeline
- Start
- 2025-12-31
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | sodium bicarbonate | Diagnostic / imaging agent | 1500 mg | — |
| Comparator | sodium bicarbonate | Diagnostic / imaging agent | 3000 mg | — |
Indications
No indication recorded.